GOSERELIN, RIBOCICLIB, ANASTROZOLE, LETROZOLE
CLEE011O12301C
Phase 3 small_molecule active
Quick answer
GOSERELIN, RIBOCICLIB, ANASTROZOLE, LETROZOLE for hormone receptor (HR)-positive, HER2-negative, early breast cancer (EBC). is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- hormone receptor (HR)-positive, HER2-negative, early breast cancer (EBC).
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active